MYX 3.79% $4.65 mayne pharma group limited

New Product Approvals, page-65

  1. 13,333 Posts.
    lightbulb Created with Sketch. 93
    MYX going through a huge accumulation here.
    Growing rev in specialised segment will surpass generic segment in 2020-2021.
    Hence, MYX will be the great mid cap bio stock for 2020-21.

    It could also be taken over by another company or it will keep moving towards the gaps at 55c & 67c.
    Due to 2019 weak FA, MYX became one of the shorted stocks. But as history repeats & experienced from $FMG, $TLS, $QAN and recently from $SYR, $ORE, $GXY, $PLS, $SDA that once FA start improving and big players release the break; the stock can gain 20-40% in matter of few weeks
    I did well with $SDA, $ORE, $GXY, $PLS, $TLS and $FMG.
    I am sure research and patience will also play out will with $MYX.

    Nicely accumulated at the bottom tight range. Just need bit more patience to let it unfold.
    https://hotcopper.com.au/data/attachments/1927/1927233-3e31994077aa45339703c030cec6dcb5.jpg
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.65
Change
0.170(3.79%)
Mkt cap ! $395.5M
Open High Low Value Volume
$4.50 $4.68 $4.47 $1.532M 331.3K

Buyers (Bids)

No. Vol. Price($)
1 206 $4.63
 

Sellers (Offers)

Price($) Vol. No.
$4.65 262 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
$4.61
  Change
0.170 ( 2.41 %)
Open High Low Volume
$4.47 $4.68 $4.47 64875
Last updated 15.59pm 14/06/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.